Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis
Top Cited Papers
Open Access
- 1 June 2005
- journal article
- other
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 64 (6) , 834-838
- https://doi.org/10.1136/ard.2004.029751
Abstract
Background: Previous work identified synovial sublining macrophage numbers as a potential biomarker for clinical efficacy in rheumatoid arthritis. Objective: To investigate the association between changes in infiltration of synovial macrophages and clinical improvement after antirheumatic treatment. Methods: 88 patients who participated in various clinical trials were studied. All patients underwent serial arthroscopy before initiation of treatment and after different time intervals. Immunohistochemical and digital image analysis were performed according to standardised procedures to detect changes in CD68+ synovial sublining macrophages in relationship to changes in the 28 joint count Disease Activity Score (DAS28). Statistical analysis was performed using one way analysis of variance, the independent samples t test, linear regression, and the standardised response mean (SRM). Results: For good, moderate, and non-responders, according to the DAS28 response criteria, there was a significant difference in the change in sublining macrophages (mean (SEM) cells/mm2 −643 (124), −270 (64), and −95 (60), respectively; pConclusion: The results suggest that changes in synovial sublining macrophages can be used to predict possible efficacy of antirheumatic treatment.Keywords
This publication has 31 references indexed in Scilit:
- Evolving concepts of rheumatoid arthritisNature, 2003
- Targeting interleukin‐1 in the treatment of rheumatoid arthritisArthritis & Rheumatism, 2002
- Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?Annual Review of Immunology, 2001
- Synovial biopsy in arthritis research: five years of concerted European collaborationAnnals of the Rheumatic Diseases, 2000
- Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor α blockade in patients with rheumatoid arthritisArthritis & Rheumatism, 2000
- Expectation bias in rheumatoid arthritis clinical trials. The anti‐CD4 monoclonal antibody experienceArthritis & Rheumatism, 1996
- Development and Validation of Response Criteria in Rheumatoid Arthritis: Steps Towards an International Consensus on Prognostic MarkersRheumatology, 1996
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane.Annals of the Rheumatic Diseases, 1994
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988